Cycles of antibiotic use and emergent antimicrobial resistance in the South African tuberculosis programme (1950-2021): A scoping review and critical reflections on stewardship

  24 May 2024

Antimicrobial resistance (AMR) is a growing concern due to the increasing dependence on antibiotics to address disease epidemics. Pharmaceuticalisation, a process in global health, has often occurred within disease programs. Tuberculosis (TB) is a notable example, accounting for one-third of AMR globally and leading cause of death in low- and middle-income countries. A scoping review of TB science in South Africa over 70 years identified cycles of programmatic responses to new drug availability and drug resistance, intersecting with cycles of pharmaceuticalisation. This analysis provides a starting point for research exploring these cycles and their implications for stewardship in TB and AMR communities.

Further reading: Glob Public Health
Author(s): Rene Raad et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed